Stay updated with breaking news from Admp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of Adamis Pharmaceuticals (NASDAQ:ADMP – Get Rating) in a report released on Tuesday. The firm set a “sell” rating on the specialty pharmaceutical company’s stock. Separately, Zacks Investment Research lowered shares of Adamis Pharmaceuticals from a “buy” rating to a “hold” rating in a research note on Thursday, June 2nd. […]
Adamis Pharmaceuticals (NASDAQ:ADMP – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Friday, Zacks.com reports. The firm presently has a $0.50 price target on the specialty pharmaceutical company’s stock. Zacks Investment Research‘s price target would indicate a potential upside of […]
It says something about this world that people get awards for what they manage to make sure other people don’t get around to doing.
Equities analysts forecast that Adamis Pharmaceuticals Co. (NASDAQ:ADMP – Get Rating) will report $4.12 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have issued estimates for Adamis Pharmaceuticals’ earnings. The highest sales estimate is $7.84 million and the lowest is $400,000.00. The business is scheduled to issue its next […]
David J. Marguglio, Co-Founder and Chief Business Officer, Appointed President and CEO Dennis J. Carlo, Ph.D., Has Retired as Both CEO and Board Director ...